Cargando…

Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study

BACKGROUND: Viral infection is associated with a significant rewire of the host metabolic pathways, presenting attractive metabolic targets for intervention. METHODS: We chart the metabolic response of lung epithelial cells to SARS-CoV-2 infection in primary cultures and COVID-19 patient samples and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ehrlich, Avner, Ioannidis, Konstantinos, Nasar, Makram, Abu Alkian, Ismaeel, Daskal, Yuval, Atari, Nofar, Kliker, Limor, Rainy, Nir, Hofree, Matan, Shafran Tikva, Sigal, Houri, Inbal, Cicero, Arrigo, Pavanello, Chiara, Sirtori, Cesare R, Cohen, Jordana B, Chirinos, Julio A, Deutsch, Lisa, Cohen, Merav, Gottlieb, Amichai, Bar-Chaim, Adina, Shibolet, Oren, Mandelboim, Michal, Maayan, Shlomo L, Nahmias, Yaakov
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2023
Materias:	Cell Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937660/ https://www.ncbi.nlm.nih.gov/pubmed/36705566 http://dx.doi.org/10.7554/eLife.79946

Ejemplares similares

Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic
por: Fratty, Ilana S., et al.
Publicado: (2022)

Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022
por: Atari, Nofar, et al.
Publicado: (2022)

Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
por: Chaouat, Abigael E., et al.
Publicado: (2022)

Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel
por: Jurkowicz, Menucha, et al.
Publicado: (2023)

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
por: Lustig, Yaniv, et al.
Publicado: (2021)

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season
por: Moss, Stephen, et al.
Publicado: (2023)

Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients
por: Peled, Yael, et al.
Publicado: (2023)

COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022
por: Kliker, Limor, et al.
Publicado: (2022)

Efficacy of Preexposure Prophylaxis with Monoclonal-Antibody AZD7442 (tixagevimab-cilgavimab) Against Sars-Cov-2 Variants in Patients with CLL
por: Benjamini, Ohad, et al.
Publicado: (2022)

High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients
por: Davidov, Yana, et al.
Publicado: (2022)

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic
por: Cohen, Dani, et al.
Publicado: (2023)

The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021
por: Zuckerman, Neta, et al.
Publicado: (2021)

Disinfection of SARS-CoV-2 by UV-LED 267 nm: comparing different variants
por: Atari, Nofar, et al.
Publicado: (2023)

Proof-of-concept for effective antiviral activity of an in silico designed decoy synthetic mRNA against SARS-CoV-2 in the Vero E6 cell-based infection model
por: Atari, Nofar, et al.
Publicado: (2023)

Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity
por: Kuzmina, Alona, et al.
Publicado: (2023)

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
por: Nemet, Ital, et al.
Publicado: (2021)

Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2
por: Lustig, Yaniv, et al.
Publicado: (2021)

Disruptive behaviors among nurses in Israel – association with listening, wellbeing and feeling as a victim: a cross-sectional study
por: Tikva, Sigal Shafran, et al.
Publicado: (2019)

Workplace violence in a tertiary care Israeli hospital - a systematic analysis of the types of violence, the perpetrators and hospital departments
por: Shafran-Tikva, Sigal, et al.
Publicado: (2017)

The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trial
por: Biber, Asaf, et al.
Publicado: (2022)

Violence against physicians and nurses in a hospital: How does it happen? A mixed-methods study
por: Shafran-Tikva, Sigal, et al.
Publicado: (2017)

(7) Cellular and Humoral Responses to Vaccination Before or after SARS-CoV-2 Infection - Bridging the Knowledge Gap to End the Pandemic for Heart Transplant Recipients
por: Peled, Y., et al.
Publicado: (2023)

(8) 5th Dose Bivalent Omicron-Containing Booster Vaccine Against Covid-19 in Heart Transplant Recipients
por: Peled, Y., et al.
Publicado: (2023)

(6) BNT162b2-Vaccine-Induced Neutralization Responses are Immune Correlates of Clinical Protection Against SARS-CoV-2 in Heart Transplant Recipients
por: Peled, Y., et al.
Publicado: (2023)

The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R
por: Mor, Orna, et al.
Publicado: (2021)

Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients
por: Davidov, Yana, et al.
Publicado: (2023)

Reduced neutralization efficacy against SARS-CoV-2 Omicron variant after third boost of mRNA BNT162 vaccine among liver transplant recipients
por: Davidov, Yana, et al.
Publicado: (2022)

Network-based stratification of tumor mutations
por: Hofree, Matan, et al.
Publicado: (2013)

RepTar: a database of predicted cellular targets of host and viral miRNAs
por: Elefant, Naama, et al.
Publicado: (2011)

CCAAT/Enhancer-Binding Protein Homologous (CHOP) Protein Promotes Carcinogenesis in the DEN-Induced Hepatocellular Carcinoma Model
por: Scaiewicz, Viviana, et al.
Publicado: (2013)

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
por: Israeli, Ma’ayan, et al.
Publicado: (2022)

Lytic Reactivation of the Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations
por: Atari, Nofar, et al.
Publicado: (2022)

Real-World Management of Patients with Primary Biliary Cholangitis—A Retrospective Study from a Tertiary Medical Center in Israel
por: Yehezkel, Eyal, et al.
Publicado: (2021)

Access-related infections in two haemodialysis units: results of a nine-year intervention and surveillance program
por: Gork, Ittamar, et al.
Publicado: (2019)

Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer
por: Chowdhury, Saikat, et al.
Publicado: (2021)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

Association Between Exposure Characteristics and the Risk for COVID-19 Infection Among Health Care Workers With and Without BNT162b2 Vaccination
por: Oster, Yonatan, et al.
Publicado: (2021)

Emergency department targeted screening for hepatitis C does not improve linkage to care
por: Houri, Inbal, et al.
Publicado: (2020)

Challenges in identifying cancer genes by analysis of exome sequencing data
por: Hofree, Matan, et al.
Publicado: (2016)

Interventions to Support Integrated Psychological Care and Holistic Health Outcomes in Paediatrics
por: Shafran, Roz, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h22pr8tujqbsa6rbvm6clagga0